Partner with ArcentLabs

Evidence-first AI for life-science R&D.
Built for decisions that are too important for black-box models

ArcentLabs is a deep-tech biotechnology company developing uncertainty-aware computational systems for therapeutic discovery, bioprocess development and clinical research — helping scientists make better decisions before costly experiments, validation studies and trials.

Where we work

Therapeutic Discovery

Computational models and discovery programs for prioritising biological hypotheses and therapeutic interventions before expensive validation.

Bioprocess Development

Clinical Research

Hybrid mechanistic and machine-learning systems for data-efficient experimental design and process optimisation.

Auditable AI for cohort quality, clinical-data enhancement, protocol design and more representative clinical development.

Platforms & Programs

CohortWeave

Clinical and imaging cohort intelligence
Constraint-first generation, completion, balancing and harmonisation of multimodal research cohorts.

ImmunoCensus

Therapeutic discovery · Parkinson's disease
A preclinical discovery program investigating pharmacologic potentiation of VPS13C-dependent lysosomal repair.

HostBridge

Virtual aged-tissue modelling
Uncertainty-aware prioritisation of geroprotective interventions before experimental validation.

Lysosomal Repair Program

Clinical trial access intelligence
Measures how individual eligibility criteria affect access to clinical trials before protocols are finalised.

GEROTWIN

Adaptive bioprocess modelling
Data-efficient media and feed optimisation across mammalian cell lines and process contexts.